Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a)

被引：5
|
作者：
Grützmacher P. [1 ]
Öhm B. [1 ]
Szymczak S. [1 ]
Dorbath C. [1 ]
Brzoska M. [1 ]
Kleinert C. [1 ]
机构：
[1] 2nd Medical Clinic – Nephrology, Hypertension and Vascular Diseases, AGAPLESION Markus-Hospital, Frankfurt/Main
来源：
Clinical Research in Cardiology Supplements | 2017年 / 12卷 / Suppl 1期
关键词：
Cardiovascular prevention; Lipoprotein (a); Lp (a) apheresis; Target LDL cholesterol;
D O I：
10.1007/s11789-017-0090-3
中图分类号：
学科分类号：
摘要：
General lipoprotein (Lp) (a) screening can help to identify patients at high risk for cardiovascular disease. Non-invasive methods allow early detection of clinically asymptomatic incipient atherosclerotic disease. Medical treatment options are still unsatisfactory. Lp(a) apheresis is an established treatment in Germany for secondary prevention of progressive cardiovascular disease. Statin-based lowering of LDL cholesterol and thrombocyte aggregation inhibitors still represent the basis of medical treatment. Target levels for LDL-cholesterol should be modified in patients with hyperlipoproteinemia (a). © 2017, The Author(s).
引用
收藏
页码：22 / 26
页数：4
相关论文
共 50 条
  • [1] Primary and Secondary Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease
    Ali, Sehrish
    Dave, Natasha
    Virani, Salim S.
    Navaneethan, Sankar D.
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2019, 21 (09)
  • [2] Primary and Secondary Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease
    Sehrish Ali
    Natasha Dave
    Salim S. Virani
    Sankar D. Navaneethan
    [J]. Current Atherosclerosis Reports, 2019, 21
  • [3] Cardiovascular Disease in Women Primary and Secondary Cardiovascular Disease Prevention
    Sanghavi, Monika
    Gulati, Martha
    [J]. OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2016, 43 (02) : 265 - +
  • [4] Cardiovascular disease prevention and markers of hyperlipoproteinemia
    Gaddi, Antonio V.
    Malvi, Cristina
    [J]. FUTURE LIPIDOLOGY, 2007, 2 (03): : 255 - 258
  • [5] Aspirin for Primary and Secondary Prevention of Cardiovascular Disease
    Godley, Robert W.
    Hernandez-Vila, Eduardo
    [J]. TEXAS HEART INSTITUTE JOURNAL, 2016, 43 (04): : 318 - 319
  • [6] ALLOPURINOL FOR PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE
    Chandrashekar, Rakshita
    Kannegolla, Karthik
    Toledo, Louis
    Beam, Craig
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2015, 30 : S98 - S98
  • [7] Statins for Secondary Cardiovascular Disease Prevention for Older Primary Care Patients
    Niska, Richard
    Han, Beth
    [J]. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2009, 101 (07) : 705 - 710
  • [8] Underutilization of aspirin in hemodialysis patients for primary and secondary prevention of cardiovascular disease
    Dempster, DW
    Rosenstock, JL
    Schwimmer, JA
    Panagopoulos, G
    DeVita, MV
    Michelis, MF
    [J]. CLINICAL NEPHROLOGY, 2005, 64 (05) : 371 - 377
  • [9] Cardiovascular Disease Prevention: The Continuum of Primary and Secondary Prevention Preface
    Deedwania, Prakash
    [J]. CARDIOLOGY CLINICS, 2011, 29 (01) : XI - XIII
  • [10] Cardiovascular disease: Different strategies for primary and secondary prevention?
    Hobbs, FDR
    [J]. HEART, 2004, 90 (10) : 1217 - 1223
12345